Role of international registries in enhancing the care of familial hypercholesterolaemia

International Journal of Evidence-Based Healthcare

Volumn 11, Issue 2, 2013, Pages 134-139

  Hammond, Emma ^a   Watts, Gerald F ^b   Rubinstein, Yaffa ^c   Farid, Waleed ^d   Livingston, Michael ^e   Knowles, Joshua W ^f   Lochmüller, Hanns ^g   Bellgard, Matthew ^h   Dawkins, Hugh Js ^a,h,i,j  

^a Western Australian Department of Health   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d FH Family Support Group of Western Australia   (Australia)

^e The International FH Foundation   (United Kingdom)

^f STANFORD UNIVERSITY   (United States)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h MURDOCH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j CURTIN UNIVERSITY   (Australia)

more..

Author keywords

Disease registry; Familial hypercholesterolaemia; Health economic evaluations; Model of care; Open source; Web based

Indexed keywords

EID: 84878995402     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1111/1744-1609.12023     Document Type: Note

References (30)

1. Austin M, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolaemia: a HuGE prevalence review. Am J Epidemiol 2004; 160: 407-420.
2. Versmissen J, Oosterveer DM, Yazdanpanah M etal. Efficacy of statins in familial hypercholesterolemia: a long term cohort study. Br Med J 2008; 337: a2423.
3. Watts GF, Sullivan D, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM. Familial hypercholesterolaemia: a model of care for Australasia. Atherosc Suppl 2011; 12: 221-263.
4. Austin M, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004; 160: 421-429.
5. Al-Sarraf A, Allard M, Martinka M, Frohlich J. Regional and national familial hypercholesterolemia registries: present international application, importance, and needs for Canada. Can J Cardiol 2013; 29: 6-9.
6. Hobbs H, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-466.
7. Day I, Whittall RA, O'Dell SD etal. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 10: 116-127.
8. Heath K, Gahan M, Whittall RA etal. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 2001; 154: 243-246.
9. National Institute for Health and Clinical Excellence TNCCfPC. NICE clinical guideline 71: identification and management of familial hypercholesterolaemia. 2008. Accessed 24 May 2013. Available from: http://www.nice.org.uk/nicemedia/pdf/CG071NICEGuidelinepdf
10. Tonkin A, Watts GF. Into the future: diversifying lipid management. Lancet 2012; 380: 1971-1974.
11. Hovingh K, Besseling J, Kastelein J. Efficacy and safety of mipomersen sodium (Kynamro). Expert Opin Drug Saf 2013; doi: 10.1517/14740338.2013.793670.
12. Watts GF, Juniper A, van Boxmeer F, Ademi Z, Liew D, O'Leary P. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and healtheconomic evaluations. Int J Evid Based Healthc 2012; 10: 211-221.
13. Clark A, Findlay IN. Improving evidence based cardiac care and policy implementation over the patient journey: the potential of coronary heart disease registers. Heart 2005; 91: 1127-1130.
14. Evans S, Bohensky M, Cameron PA, McNeil J. A survey of Australian clinical registries: can quality of care be measured? Intern Med J 2011; 41: 42-48.
15. Rumsfeild J, Dehmer GJ, Brindis RG. The national cardiovascular data registry - its role in benchmarking and improving quality. US Cardiol 2009; 6: 11-15.
16. Bellgard MI, Macgregor A, Janon F etal. A modular approach to disease registry design: successful adoption of an internet-based rare disease registry. Hum Mutat 2012; 33: E2356-2366.
17. Rodrigues M, Hammond-Tooke G, Kidd A etal. The New Zealand neuromuscular disease registry. J Clin Neurosci 2012; 19: 1749-1750.
18. Doulet N. Disease registries in Europe. Orphanet report series, rare diseases collection. 2011. Accessed 24 May 2013. Available from: http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf
19. Betteridge D, Broome K, Durrington PN etal.; Scientific Steering Committee of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Br Med J 1991; 303: 893-896.
20. Betteridge DJ, Broome K, Durrington PN etal. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999; 142: 105-112.
21. Neil A, Cooper J, Betteridge J etal. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008; 29: 2625-2633.
22. Group. SSCobotSBR. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999; 142: 105-112.
23. Humphries S, Whittall RA, Hubbart CS etal.; Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet 2006; 43: 943-949.
24. Toleikyte I, Retterstøl K, Leren TP, Per Iversen O. Pregnancy outcomes in familial hypercholesterolemia. Circulation 2011; 124: 1606-1614.
25. Care ACoSaQiH. Strategic principles for a national approach to Australian clinical quality registries. 2013. Accessed 24 May 2013. Available from: http://www.safetyandquality.gov.au/our-work/information-strategy/clinical-quality-registries/
26. Evans SLB, Cameron PA. Clinical registries: the urgent need to address ethical hurdles. Med J Aust 2013; 198: 134-135.
27. Larsson SL, Lawler P, Siverstein MB. From concept to reality: putting value-based health care into practice in Sweden. 2010. Accessed 24 May 2013. Available from: http://www.bcgperspectives.com/content/articles/biopharma_health_care_payers_providers_health_care_from_concept_to_reality/
28. Soderlund N, Kent J, Lawyer P, Larsson S. Progress toward value-based health care: lessons from 12 countries. 2012. Accessed 24 May 2013. Available from: http://www.isc.hbs.edu/pdf/BCG_Progress_Toward_VBHC_June2012.pdf
29. Bufalino V, Masoudi FA, Stranne KD etal. on behalf of the American Heart Association Advocacy Coordinating Committee. AHA policy statement: the American Heart Association's recommendations for expanding the applications of existing and future clinical registries. Circulation 2011; 123: 2167-2179.
30. Ingles J, McGaughran J, Vohra J etal. Establishment of an Australian national genetic heart disease registry. Heart Lung Circ 2008; 17: 463-467.